2D cultures often fall short in drug screening when it comes to clinical predictivity, but 3D models and high content services allow accurate and clinically relevant screens.
Empower your lead identification search with targeted statistical analysis that moves beyond standard IC50 readouts to structural investigations of your candidates.
Download this poster to explore how to filter out suitable leads with:
- Defined project workflows
- A robust offering of oncology assays
- Reporting of phenotypic changes
- Screens performed in physiologically relevant systems
